METTL3 and lung adenocarcinoma: In lung adenocarcinoma (LUAD), METTL3 triggers the oncogenic molecule c-MYC by enhancing the stability of lncRNA LCAT3, interacting with the upstream protein FUBP1, and promoting tumor cell growth, infiltration, and dissemination (Qian et al., 2021).